-
Semaglutide Oral Tablets 7mgProduct Name: Semaglutide Oral Tablet 7mg Indication Type 2 diabetes mellitus; Obesity Type Innovative Drug Form Injection Target Dual GLP/GIP receptor agonist Clinical progress Phase Ⅲread more
-
BGM0504 Injection GLP-1/GIP Receptor AgonistProduct Name: BGM0504 Injection GLP-1/GIP receptor agonist Indication Type 2 diabetes mellitus; Obesity Type Innovative Drug Form Injection Target Dual GLP/GIP receptor agonist Clinicalread more
-
Incretin Analogs BGM0504Product Name: Incretin Analogs BGM0504 Indication Type 2 diabetes mellitus; Obesity Type Innovative Drug Form Injection Target Dual GLP/GIP receptor agonist Clinical progress Phase Ⅲread more
-
Semaglutide Weight Loss TabletsProduct Name: Semaglutide weight loss tablets Indication Type 2 diabetes mellitus; Obesity Type Innovative Drug Form Injection Target Dual GLP/GIP receptor agonist Clinical progressread more
-
Semaglutide TabletsProduct Name: Semaglutide tablets Indication Type 2 diabetes mellitus; Obesity Type Innovative Drug Form Injection Target Dual GLP/GIP receptor agonist Clinical progress Phase Ⅲread more
-
Argatroban InjectionProduct Name: Argatroban Injection Cas. 74863-84-6 Molecular Formula C23H36N6O5S Molecular Weight 508.63 Appearance White to off-white powderread more
-
Fondaparinux Sodium InjectionProduct Name: Fondaparinux Sodium Injection Cas. 114870-03-0 Molecular Formula C31H43N3Na10O49S8 Molecular Weight 1728.08 Appearance Colorless liquidread more
-
Micafungin Sodium InjectionProduct Name: Micafungin Sodium Injection Cas. 208538-73-2 Molecular Formula C56H72N9NaO23S Molecular Weight 1294.28 Appearance White or off-white solidread more
-
Eribulin Mesylate InjectionProduct Name: Eribulin Mesylate Injection Cas. 441045-17-6 Molecular Formula C41H63NO14S Molecular Weight 826.01 Appearance Colorless liquidread more
-
Tiotropium Bromide SMIProduct Name: Tiotropium Bromide Cas. 136310-93-5 Molecular Formula C19H22BrNO4S2 Molecular Weight 472.42 Appearance White or off-white powderread more
-
Octreotide Acetate LAR InjectionProduct Name: Octreotide Acetate LAR Injection Cas. 83150-76-9 Molecular Formula C49H66N10O10S2 Molecular Weight 1019.24 Appearance Colorless liquidread more
-
Triptorelin Pamoate LAR InjectionProduct Name: Triptorelin Pamoate LAR Injection Cas. 57773-63-4 Molecular Formula C64H82N18O13 Molecular Weight 1311.45 Appearance White to off-white powderread more
Feb 20, 2024 — Notably, domestic innovation is flourishing, with five first-in-class drugs, including Glumetinib, a c-Met inhibitor from Haihe Biopharma; Leritrelvir, a 3CL protease inhibitor from...
Jun 24, 2023 — In the development of an optimal drug delivery system, recent drug delivery systems are recognized to be the newest developments and innovative understanding of the...
Apr 11, 2022 — 2. Advantages and Disadvantages of Using FDCs. Despite the growing popularity of FDC-type drugs and a significant increase in the formulations available on the market for various...
Oct 1, 2021 — The key to supporting drug innovation is to increase NIH funding of the efforts that gives rise to these new companies, cut the costs and accelerate the speed of clinical trials, and...
Dec 6, 2023 — Significant advancements in new targeted medications, including small molecules (e.g., KRASG12C inhibitors), bispecific antibodies, antibody drug conjugates, and cellular...
The development of innovative drug formulations plays a crucial role in enhancing drug efficacy, improving patient safety, and promoting better therapeutic outcomes ... drugs with improved precision...
